The Lymphoma Program is dedicated to the integration of laboratory and clinical research to increase our understanding of lymphoma and to develop new, more effective therapies for these conditions. The principal areas of research focus on understanding the genetic determinants of tumor biology, exploiting the relationship of lymphoma with the immune system to develop immunotherapy and in new drug development. We are part of a National Cancer Institute-funded Specialized Programs of Research Excellence (SPORE) grant and participate in COG and internal lymphoma studies within Texas Children’s Cancer Center and the Cell and Gene Therapy Program.